510(k) Report

510(k) · Cleared

Cleared

ReWalk P6.0

K221696510(k) TraditionalCleared Mar 2, 2023265-day reviewClass II21 CFR 890.3480

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Re Walk Robotics, Ltd. · PHL Powered Exoskeleton

Cleared on Mar 2, 2023 as substantially equivalent to K200032 (Re Walk Robotics, Ltd., 2020) after a 265-day review. Its family tree reaches back 2 generations to 2016. 2 later devices descend from it.

Decided
Mar 2, 2023
Review
265 days
Class
Class II
Product code
PHL
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K160987 (2016). 2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2025: 1 descendant cleared2026: 1 descendant clearedReference device: K160987 · ReWalk (TM) · Rewalk Robotics, Inc. · 2016 · recalledK160987 · ReWalk (TM) · Rewalk Robotics, Inc. · 2016 · recalledK200032 · ReWalk P6.0 · Re Walk Robotics, Ltd. · 2020 · recalled201620182020202220242026
Descendants, by generation 1 generation forward: 2 descendants K200032 · ReWalk P6.0 · Re Walk Robotics, Ltd. · 2020 · recalledK160987 · ReWalk (TM) · Rewalk Robotics, Inc. · 2016 · recalled0
  1. Root · 2 generations backK160987 ReWalk (TM)Rewalk Robotics, Inc. · 2016 · Recalled
  2. 1 generation backK200032 ReWalk P6.0Re Walk Robotics, Ltd. · 2020 · Recalled
  3. This deviceK221696 ReWalk P6.0Re Walk Robotics, Ltd. · 2023
  4. Descendant · cites it directly · 0 of its ownK254198 Trexo TheoTrexo Robotics, Inc. · 2026
  5. Descendant · cites it directly · 0 of its ownK241822 ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K254198Trexo TheoTrexo Robotics, Inc. · 2026 · cites it directly0descendants
  • K241822ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K160987ReWalk (TM)Rewalk Robotics, Inc.20162
−1K200032ReWalk P6.0Re Walk Robotics, Ltd.20201
0 (this device)K221696ReWalk P6.0Re Walk Robotics, Ltd.2023—
+1K254198Trexo TheoTrexo Robotics, Inc.2026—
+1K241822ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202610
FIG. 1 — Lineage of K221696, 2016–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PHL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PHL device

  1. #1 K250904 Atalante Xscore 15.0 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K200032ReWalk P6.0
Summary page 5
…Marketed Predicate Device Predicate Manufacturer: ReWalk Robotics Ltd. Predicate Trade Name: ReWalk P6.0 Predicate 510(k): K200032 6. Legally Marketed Reference Device Reference Device Manufacturer: ReWalk Robotics Ltd. Reference Device Trade Name…
Re Walk Robotics, Ltd.20201
†K160987ReWalk (TM)Rewalk Robotics, Inc.20162

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K254198Trexo TheoTrexo Robotics, Inc.20260
K241822ReWalk® 7 Personal Exoskeleton (50-20-0005)Rewalk Robotics Ltd. Dba Lifeward20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 3.8 years on median.
  • 2 of the 2 ancestors have a recall of any class.
  • Of its descendants, K254198 (Trexo Robotics, Inc., 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All PHL devices

PHL Powered Exoskeleton: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · PHL

2in 2025

2014: 12016: 42017: 22018: 22019: 22020: 42021: 12022: 32023: 22024: 12025: 22026 (partial year): 2
2007high 4 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PHL

177in 2022

2016: 145 days median2020: 110 days median2022: 177 days median
2007high 177 (2022) · low 110 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PHL

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PHL

6in 2025

2015: 12016: 42017: 82018: 212020: 32021: 22022: 22023: 12024: 62025: 6
2007high 21 (2018) · low 0 (2007)2025

MAUDE reports naming product code PHL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20150—01
2016414504
20172—18
20182—021
20192—00
2020411003
20211—02
2022317702
20232—01
20241—06
20252—06
20262—0—

What is it indicated for?

The ReWalk® P6.0 fits to the lower limbs and part of the upper body and is intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions in home and community settings with supervision of a specially certified companion in accordance with the user assessment and training certification program. The device is also intended to enable individuals with spinal cord injury at levels T4 to T6 to perform ambulatory…

Read the full statement (116 words)

The ReWalk® P6.0 fits to the lower limbs and part of the upper body and is intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions in home and community settings with supervision of a specially certified companion in accordance with the user assessment and training certification program. The device is also intended to enable individuals with spinal cord injury at levels T4 to T6 to perform ambulatory functions in rehabilitation institutions in accordance with the user assessment and training certification program. The ReWalk P6.0 is intended for indoor and outdoor use: including standing and walking on level surfaces and mild slopes and ascending and descending stairs and curbs.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K221696: ReWalk P6.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K221696

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026